|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print June 27, 2002
Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.00313.2002
Submitted on April 8, 2002
Accepted on June 24, 2002
1 Pharmacology and Cell Biophysics, University of Cincinnati, Cincinnati, OH, USA
2 Medicine, Case Western Reserve Ubiversity, Cleveland, OH, USA
3 Physiology, University of Maryland, Baltimore, MD, USA
* To whom correspondence should be addressed. E-mail: matlibma{at}uc.edu.
The goal of the study is to determine whether defects in intracellular Ca2+ signaling contribute to cardiomyopathy in streptozotocin (STZ)-induced diabetic rats. Depression in cardiac systolic and diastolic function was traced from live diabetic rats to isolated individual myocytes. The depression in contraction and relaxation in myocytes was found in parallel with depression in the rise and decline of intracellular free Ca2+ concentration ([Ca2+]i). The sarcoplasmic reticulum (SR) Ca2+ store and rates of Ca2+ release and re-sequestration into SR were depressed in diabetic rat myocytes. The rate of Ca2+ efflux via sarcolemmal Na+ -Ca2+ exchanger (NCX) was also depressed. However, there was no change in the voltage-dependent L-type Ca2+ channel current (ICa) that triggers Ca2+ release from SR. The depression in SR function was associated with decreased SR Ca2+-ATPase (SERCA2) and ryanodine receptor (RyR) proteins and increased total and non-phosphorylated phospholamban (PLB) proteins. The depression of NCX activity was associated with a decrease in its protein level. Thus, it is concluded that defects in intracellular Ca2+ signaling caused by alteration of expression and function of the proteins that regulate [Ca2+]i contribute to cardiomyopathy in STZ-induced diabetic rats. The increase in PLB, decrease in NCX, and unchanged L-type [Ca2+]channel activity in this model of diabetic cardiomyopathy are distinct from other types of cardiomyopathy.
This article has been cited by other articles:
![]() |
H. Bugger and E. D. Abel Rodent models of diabetic cardiomyopathy Dis. Model. Mech., September 1, 2009; 2(9-10): 454 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Coppola, D. Marmolino, D. Lu, Q. Wang, M. Cnop, M. Rai, F. Acquaviva, S. Cocozza, M. Pandolfo, and D. H. Geschwind Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPAR{gamma} pathway as a therapeutic target in Friedreich's ataxia Hum. Mol. Genet., July 1, 2009; 18(13): 2452 - 2461. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Shao, X. H. T. Wehrens, T. A. Wyatt, S. Parbhu, G. J. Rozanski, K. P. Patel, and K. R. Bidasee Exercise training during diabetes attenuates cardiac ryanodine receptor dysregulation J Appl Physiol, April 1, 2009; 106(4): 1280 - 1292. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Laczy, B. G. Hill, K. Wang, A. J. Paterson, C. R. White, D. Xing, Y.-F. Chen, V. Darley-Usmar, S. Oparil, and J. C. Chatham Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H13 - H28. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cheng and W. J. Lederer Calcium Sparks Physiol Rev, October 1, 2008; 88(4): 1491 - 1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Amour, X. Loyer, P. Michelet, A. Birenbaum, B. Riou, and C. Heymes Preservation of the Positive Lusitropic Effect of {beta}-Adrenoceptors Stimulation in Diabetic Cardiomyopathy Anesth. Analg., October 1, 2008; 107(4): 1130 - 1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, M. B. Cannell, A. R.J. Phillips, G. J.S. Cooper, and M.-L. Ward Altered Calcium Homeostasis Does Not Explain the Contractile Deficit of Diabetic Cardiomyopathy Diabetes, August 1, 2008; 57(8): 2158 - 2166. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Lacombe, S. Viatchenko-Karpinski, D. Terentyev, A. Sridhar, S. Emani, J. D. Bonagura, D. S. Feldman, S. Gyorke, and C. A. Carnes Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2007; 293(5): R1787 - R1797. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lin, G. P. Craig, L. Zhang, V. G. Yuen, M. Allard, J. H. McNeill, and K. M. MacLeod Acute inhibition of Rho-kinase improves cardiac contractile function in streptozotocin-diabetic rats Cardiovasc Res, July 1, 2007; 75(1): 51 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Boudina and E. D. Abel Diabetic Cardiomyopathy Revisited Circulation, June 26, 2007; 115(25): 3213 - 3223. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Li, X. Li, Y.-L. Li, C.-H. Shao, K. R. Bidasee, and G. J. Rozanski Insulin regulation of glutathione and contractile phenotype in diabetic rat ventricular myocytes Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1619 - H1629. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Gerber, B. J. Aronow, and M. A. Matlib Activation of a novel long-chain free fatty acid generation and export system in mitochondria of diabetic rat hearts Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1198 - C1207. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Vasanji, E. J. F. Cantor, D. Juric, M. Moyen, and T. Netticadan Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance Am J Physiol Cell Physiol, October 1, 2006; 291(4): C772 - C780. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. An and B. Rodrigues Role of changes in cardiac metabolism in development of diabetic cardiomyopathy Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1489 - H1506. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ayaz and B. Turan Selenium prevents diabetes-induced alterations in [Zn2+]i and metallothionein level of rat heart via restoration of cell redox cycle Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1071 - H1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yaras, M. Ugur, S. Ozdemir, H. Gurdal, N. Purali, A. Lacampagne, G. Vassort, and B. Turan Effects of Diabetes on Ryanodine Receptor Ca Release Channel (RyR2) and Ca2+ Homeostasis in Rat Heart Diabetes, November 1, 2005; 54(11): 3082 - 3088. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C Howarth, M Jacobson, O Naseer, and E Adeghate Short-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats Exp Physiol, March 1, 2005; 90(2): 237 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. M. Rundell, D. L. Geenen, P. M. Buttrick, and P. P. de Tombe Depressed cardiac tension cost in experimental diabetes is due to altered myosin heavy chain isoform expression Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H408 - H413. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Bidasee, Y. Zhang, C. H. Shao, M. Wang, K. P. Patel, U. D. Dincer, and H. R. Besch Diabetes Increases Formation of Advanced Glycation End Products on Sarco(endo)plasmic Reticulum Ca2+-ATPase Diabetes, February 1, 2004; 53(2): 463 - 473. [Abstract] [Full Text] |
||||
![]() |
J.-M. Pei, G. M. Kravtsov, S. Wu, R. Das, M. L. Fung, and T. M. Wong Calcium homeostasis in rat cardiomyocytes during chronic hypoxia: a time course study Am J Physiol Cell Physiol, December 1, 2003; 285(6): C1420 - C1428. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhong, P. J Reiser, and M. A. Matlib Gender differences in myosin heavy chain-{beta} and phosphorylated phospholamban in diabetic rat hearts Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2688 - H2693. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |